CPC Biotech Launches the Quattroflow HTX All-in-One Pump Drive for Bioprocessing
DOWNERS GROVE, Ill., Nov. 11, 2026 /PRNewswire/ -- CPC Biotech, part of PSG and Dover (NYSE: DOV) and a leading manufacturer of connectors, pumps, and flow sensors used in biopharmaceutical processing, today announced the launch of the Quattroflow HTX, an all-in-one pump drive featuring...
Covered in this story
Analyst targets on Dover Corporation
- Wells Fargo: at $192 · target $229 by Sep 2027 · Overweight via Investing.com
- BMO Capital Markets: at $202 · target $240 by Jul 2027 · Outperform via Investing.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $DOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Dover Corporation →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.